130 likes | 304 Views
Access to Medicine Index . 21 September 2010 Brussels , Wim Leereveld Journées Thématiques Médicament . 2. What we measure: A complete range of stakeholders defines the methodology of the Index. Investors. NGOs. Pharmaceutical Industry. Patients / Healthcare practitioners.
E N D
Access to Medicine Index 21 September 2010 Brussels, Wim Leereveld Journées Thématiques Médicament
What we measure: A complete range of stakeholders defines the methodology of the Index Investors NGOs Pharmaceutical Industry Patients / Healthcare practitioners Government Inter-governmental Organization Academia Experts 3
World Health Organisation • endorses Index • “What gets measured gets done” 5
The Access to Medicine Foundation is a not for profit organization and grateful to receive funding from the following organizations 7
Access to Medicine Index 21 Septembre 2010 Bruxelles, Wim Leereveld Journées Thématiques Médicament
Access to Medicine Index is endorsed by 20+ leading financial institutions – with combined AUM over US$3 trillion 9
Methodology Evolution Index 2008 Index 2010 30% 30% 30% 10% ATM Management Public Policy & Advocacy R&D Patents &Licensing Equitable Pricing Capacity Index 2010 has a matrix structured methodology, that over time will allow for an increased weighting of on the ground performance of companies Donations Philanthropy 12
‘Quality’ Captured Twice Example datapoints: Products sold in Index Countries should meet the same quality standards as those of the developed world. Product packaging, including product labeling, should be adapted to Index Country needs and languages. Example datapoint: Assisting licensees in obtaining quality management systems that conform to international quality standards; such standards include FDA, EMA and WHO Good Manufacturing Practices.